First Financial Corp Teva Pharmaceutical Industries LTD Transaction History

First Financial Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 15, 2020	SELL	$6.69 - $13.45 $1,866 - $3,752	-279 Closed	0 $0
Q3 2019 Oct 15, 2019	BUY	$6.16 - $9.6 $1,718 - $2,678	279 New	279 $2,000
Q2 2019 Jul 15, 2019	SELL	$8.12 - $15.72 $1,380 - $2,672	-170 Closed	0 $0
Q3 2018 Oct 16, 2018	SELL	$21.06 - $25.65 $2,106 - $2,565	-100 Reduced 37.04%	170 $4,000
Q1 2018 Apr 17, 2018	SELL	$16.68 - $22.07 $2,085 - $2,758	-125 Reduced 31.65%	270 $5,000
Q4 2017 Jan 16, 2018	SELL	$11.23 - $19.1 $2,594 - $4,412	-231 Reduced 36.9%	395 $8,000
Q3 2017 Oct 13, 2017	BUY	$15.41 - $32.17 $9,646 - $20,138	626	626 $11,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

Stay updated on First Financial Corp with notifications on news.